Cited by 55Advanced MRI Techniques and ApplicationsCentral Venous Catheters and HemodialysisLanthanide and Transition Metal Complexes

USPIO-enhanced MR angiography of arteriovenous fistulas in patients with renal failure

Open access
Sigovan, Monica, Gasper, Warren, Alley, Hugh F., Owens, Christopher D., Saloner, David·2012·Radiology

Abstract

PURPOSE: To determine the feasibility of using ferumoxytol-enhanced magnetic resonance (MR) angiography to depict the vasculature of hemodialysis fistulas and improve image quality compared with nonenhanced time-of-flight (TOF) MR angiography. MATERIALS AND METHODS: The study was institutional review board approved and was in compliance with HIPAA regulations. All participants provided written informed consent. TOF and first-pass ferumoxytol-enhanced MR angiography were performed in 10 patients with upper extremity autogenous fistulas. Ferumoxytol was administered as a bolus solution containing 430 μmol of elemental iron. A qualitative comparison was performed on maximum intensity projection images. Lumen depiction was evaluated by using a five-point scale. The uniformity of intraluminal signal intensity was measured as the ratio between the mean signal intensity of the entirety of the imaged fistula and its standard deviation. The contrast-to-noise ratio (CNR) between intraluminal signal and adjacent tissue was evaluated as a function of image acquisition time. Lumen depiction scores, luminal signal heterogeneity, and CNR efficiency were compared between TOF and ferumoxytol-enhanced MR angiography by using a Wilcoxon-Mann-Whitney test. RESULTS: Flow artifacts were greatly reduced by the use of ferumoxytol-enhanced MR angiography. Ferumoxytol-enhanced MR angiography had significantly better performance than TOF MR angiography as measured with the following: lumen depiction scores in all segments (mean, 4.7±0.1 [standard error of the mean]; vs 3.0±0.3 for arterial inflow, 4.1±0.3 vs 1.9±0.3 for arterial outflow, 3.7±0.3 vs 1.8±0.2 for anastomosis, and 4.5±0.2 vs 2.1±0.2 for venous outflow; P<.001), intraluminal signal homogeneity (0.3±0.02 vs 0.4±0.06, P=.005), and CNR efficiency in the venous outflow (5.1±0.6 vs 2.5±0.4, P=.01). CONCLUSION: This study demonstrates the feasibility of using ferumoxytol-enhanced MR angiography in imaging hemodialysis fistulas with consistently superior image quality compared with nonenhanced TOF MR angiography.

Integrity signals

Registry

Crossref · 10.1148/radiol.12112694

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Ferumoxytol-enhanced MRA has superior image quality compared to non-enhanced TOF MRA for assessing arteriovenous fistula integrity in kidney failure patients.

    “To assess the integrity of the fistula, ferumoxytol-enhanced MRA has been successfully employed and has shown superior image quality as compared to non-enhanced time-of-flight (TOF) MRA [188].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sigovan, M., Gasper, W., Alley, H. F., Owens, C. D., & Saloner, D.
Affiliations
  • University of California, San Francisco (US)
  • San Francisco VA Medical Center (US)
Venue
Radiology
Published
2012-11
Volume
265
Issue
2
Pages
584-590
ISSN
  • 0033-8419 (ISSN-L)
  • 1527-1315
OpenAlex
W1976111275
Cited by
55
References
15
Citations by year
2025: 2 · 2024: 4 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 2 · 2019: 4 · 2018: 6 · 2017: 7 · 2016: 5 · 2015: 2 · 2014: 11 · 2013: 2 · 2012: 1
FWCI
3.86
Type
journal article
Language
en
Open access
Locations
  • Radiology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
National Institute of Neurological Disorders and Stroke (R01NS059944)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
  • Health Sciences › Health Professions › Emergency Medical Services › Central Venous Catheters and Hemodialysis
  • Physical Sciences › Materials Science › Materials Chemistry › Lanthanide and Transition Metal Complexes
Keywords
ferumoxytol, ultrasmall superparamagnetic iron oxide, magnetic resonance angiography, arteriovenous fistula, hemodialysis fistula, renal failure, time-of-flight MR angiography, contrast-to-noise ratio, flow artifacts, iron oxide contrast agents, image quality comparison, signal homogeneity, maximum intensity projection
MeSH terms
Anastomosis, Surgical, Arteriovenous Anastomosis, Contrast Media, Dextrans, Female, Humans, Image Enhancement, Male, Sensitivity and Specificity, Reproducibility of Results, Magnetic Resonance Angiography, Renal Insufficiency, Magnetite Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review